GPT Healthcare Limited submitted its unaudited financial results for Q2 and H1 FY27 ended September 30, 2026, in compliance with Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

Q2 FY27 Performance (Quarter ended September 30, 2026):

  • Total Income: ₹138.6 crore, representing 15.2% year-over-year growth from ₹120.2 crore in Q2 FY26
  • EBITDA: ₹29.8 crore, up 23.9% from ₹24.1 crore in Q2 FY26
  • EBITDA Margin: 21.5%, improved from 20.0% in Q2 FY26
  • Profit After Tax: ₹15.4 crore, showing 45.2% growth from ₹10.6 crore in Q2 FY26
  • PAT Margin: 11.1%, improved from 8.8% in Q2 FY26

Quarter-over-Quarter Performance (Q2 FY27 vs Q1 FY27):

  • Total Income growth of 8.1% from ₹128.2 crore in Q1 FY27
  • EBITDA growth of 13.8% from ₹26.2 crore in Q1 FY27
  • Profit After Tax growth of 21.0% from ₹12.7 crore in Q1 FY27

H1 FY27 Performance (Half year ended September 30, 2026):

  • Total Income: ₹266.8 crore, representing 16.5% year-over-year growth from ₹228.9 crore in H1 FY26
  • EBITDA: ₹56.0 crore, up 30.3% from ₹43.0 crore in H1 FY26
  • EBITDA Margin: 21.0%, expanded from 18.8% in H1 FY26
  • Profit After Tax: ₹28.1 crore, showing 53.9% growth from ₹18.3 crore in H1 FY26
  • PAT Margin: 10.5%, improved from 8.0% in H1 FY26

Operational Highlights

Q2 FY27 Operational Metrics:

  • Average Revenue Per Occupied Bed (ARPOB): ₹40,721, registering 7.1% year-over-year growth
  • Occupancy Rate: 50.3% across the hospital network, including the newly operationalized Raipur facility

H1 FY27 Operational Metrics:

  • Network Occupancy: 47.9% in H1 FY27 compared to 44.7% in H1 FY26
  • ARPOB: ₹41,490, representing 8.1% year-over-year growth
  • Inpatient Revenue Growth: 16.4% year-over-year
  • Outpatient Revenue Growth: 13.5% year-over-year

Hospital-Specific Achievements:

  • ILS Dum Dum and ILS Raipur collectively performed over 750 renal transplants
  • ILS Howrah with MAKO robot nearing 100 robotics procedures
  • ILS Agartala delivered over 3,200 radiation therapy procedures
  • ILS Salt Lake surpassed 850 robotic surgeries
  • Jamshedpur hospital remains on track for completion by Q4 FY27

Management Commentary

Dr. Om Tantia, Chairman of GPT Healthcare, commented that the company delivered strong performance driven by disciplined execution, improving operational metrics, and stronger contribution from mature hospitals. The growth was supported by higher patient volumes, improved throughput, and better utilization of the hospital network.

Forward Outlook

The company remains focused on unlocking operating leverage, expanding its footprint, strengthening advanced clinical capabilities, and adopting an asset-light expansion model. Key focus areas include capacity utilization, specialty diversification, and disciplined growth.

Company Background

GPT Healthcare Limited operates the ILS Hospitals brand with five multi-specialty hospitals:

  • ILS Salt Lake: 85 beds
  • ILS Agartala: 205 beds
  • ILS Dumdum: 155 beds
  • ILS Howrah: 116 beds
  • ILS Raipur: 158 beds

Total network capacity: over 719 beds across Eastern India markets